In the last 12 months, insiders at BIORA THERAPEUTICS, INC. ($BIORQ) filed 29 transactions with the SEC: 0 open-market purchases totaling $0 and 0 sales totaling $0. Net insider sentiment: neutral.
BIORA THERAPEUTICS, INC. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- MOHANTY ADITYA P. (Chief Executive Officer) — 2 transactions totaling $47,492
- dEsparbes Eric (Chief Financial Officer) — 2 transactions totaling $18,646
- NEUMANN CLARKE (See Remarks) — 2 transactions totaling $17,841
- Kotzin Brian L. (Not found) — 2 transactions totaling $0
- Alter Jeffrey D. (Not found) — 2 transactions totaling $0
View all SEC Filings for BIORA THERAPEUTICS, INC. (BIORQ).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 12, 2024 | Athyrium Opportunities III Co-Invest 1 LP | Not found | A | 11.00% / 13.00% Convertible Senior Secured Notes due 2028 | 1195994 | $0.00 | 19,595,899.8900 | 4,522,702 | 6.50% | 26.44% |
| Aug. 15, 2024 | MOHANTY ADITYA P. | Chief Executive Officer | F | Common Stock | 70883 | $0.67 | 1,468,609.0000 | 30,313,428 | 4.60% | 0.23% |
| Aug. 15, 2024 | NEUMANN CLARKE | See Remarks | F | Common Stock | 26629 | $0.67 | 465,564.0000 | 30,313,428 | 5.41% | 0.09% |
| Aug. 15, 2024 | dEsparbes Eric | Chief Financial Officer | F | Common Stock | 27830 | $0.67 | 575,832.0000 | 30,313,428 | 4.61% | 0.09% |
| Aug. 12, 2024 | Athyrium Opportunities III Co-Invest 1 LP | Not found | D | 11.00%/13. 00% Convertible Senior Secured Notes due 2028 | 18399906 | $0.00 | 0.0000 | 30,313,428 | 100.00% | 60.70% |
| Aug. 12, 2024 | Athyrium Opportunities III Co-Invest 1 LP | Not found | A | 11.00%/13. 00% Convertible Senior Secured Notes due 2028 | 18399906 | $0.00 | 18,399,906.0000 | 30,313,428 | 9999.99% | 60.70% |
| Aug. 12, 2024 | Athyrium Opportunities III Co-Invest 1 LP | Not found | D | Warrant | 323886 | $0.00 | 0.0000 | 30,313,428 | 100.00% | 1.07% |
| Aug. 12, 2024 | Athyrium Opportunities III Co-Invest 1 LP | Not found | A | Warrant | 323886 | $0.00 | 323,886.0000 | 30,313,428 | 9999.99% | 1.07% |
| Aug. 12, 2024 | Athyrium Opportunities III Co-Invest 1 LP | Not found | D | Warrant | 500249 | $0.00 | 0.0000 | 30,313,428 | 100.00% | 1.65% |
| Aug. 12, 2024 | Athyrium Opportunities III Co-Invest 1 LP | Not found | A | Warrant | 500249 | $0.00 | 500,249.0000 | 30,313,428 | 9999.99% | 1.65% |
| Aug. 12, 2024 | Athyrium Opportunities III Co-Invest 1 LP | Not found | D | Warrant | 2085372 | $0.00 | 0.0000 | 30,313,428 | 100.00% | 6.88% |
| Aug. 12, 2024 | Athyrium Opportunities III Co-Invest 1 LP | Not found | A | Warrant | 2085372 | $0.00 | 2,085,372.0000 | 30,313,428 | 9999.99% | 6.88% |
| Aug. 12, 2024 | Athyrium Opportunities III Co-Invest 1 LP | Not found | D | Warrant | 5039236 | $0.00 | 0.0000 | 30,313,428 | 100.00% | 16.62% |
| Aug. 12, 2024 | Athyrium Opportunities III Co-Invest 1 LP | Not found | A | Warrant | 5039236 | $0.00 | 5,039,236.0000 | 30,313,428 | 9999.99% | 16.62% |
| Aug. 12, 2024 | Athyrium Opportunities III Co-Invest 1 LP | Not found | D | Warrant | 457250 | $0.00 | 0.0000 | 30,313,428 | 100.00% | 1.51% |
| Aug. 12, 2024 | Athyrium Opportunities III Co-Invest 1 LP | Not found | A | Warrant | 457250 | $0.00 | 457,250.0000 | 30,313,428 | 9999.99% | 1.51% |
| July 3, 2023 | Athyrium Opportunities III Co-Invest 1 LP | Not found | A | Warrant | 457250 | $0.00 | 457,250.0000 | 0 | 9999.99% | 0.00% |
| July 2, 2024 | Athyrium Opportunities III Co-Invest 1 LP | Not found | A | 11.00%/13.00% Convertible Senior Secured Notes due 2028 | 1016906 | $0.00 | 18,399,906.0000 | 30,313,428 | 5.85% | 3.35% |
| June 5, 2024 | Powell Lynne | Not found | A | Common Stock | 12500 | $0.00 | 30,746.0000 | 30,313,428 | 68.51% | 0.04% |
| June 5, 2024 | Powell Lynne | Not found | A | Stock Option (Right to Buy) | 12500 | $0.00 | 12,500.0000 | 30,313,428 | 9999.99% | 0.04% |
| June 5, 2024 | Howe Jill Ann | Not found | A | Common Stock | 12500 | $0.00 | 31,916.0000 | 30,313,428 | 64.38% | 0.04% |
| June 5, 2024 | Howe Jill Ann | Not found | A | Stock Option (Right to Buy) | 12500 | $0.00 | 12,500.0000 | 30,313,428 | 9999.99% | 0.04% |
| June 5, 2024 | Kotzin Brian L. | Not found | A | Common Stock | 12500 | $0.00 | 30,746.0000 | 30,313,428 | 68.51% | 0.04% |
| June 5, 2024 | Kotzin Brian L. | Not found | A | Stock Option (Right to Buy) | 12500 | $0.00 | 12,500.0000 | 30,313,428 | 9999.99% | 0.04% |
| June 5, 2024 | Alter Jeffrey D. | Not found | A | Common Stock | 12500 | $0.00 | 31,546.0000 | 30,313,428 | 65.63% | 0.04% |
| June 5, 2024 | Alter Jeffrey D. | Not found | A | Stock Option (Right to Buy) | 12500 | $0.00 | 12,500.0000 | 30,313,428 | 9999.99% | 0.04% |
| Feb. 15, 2024 | dEsparbes Eric | Chief Financial Officer | A | Common Stock | 325000 | $0.00 | 603,662.0000 | 0 | 116.63% | 0.00% |
| Feb. 15, 2024 | NEUMANN CLARKE | See Remarks | A | Common Stock | 230000 | $0.00 | 492,193.0000 | 0 | 87.72% | 0.00% |
| Feb. 15, 2024 | MOHANTY ADITYA P. | Chief Executive Officer | A | Common Stock | 819000 | $0.00 | 1,539,492.0000 | 0 | 113.67% | 0.00% |